http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0720849-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a452aeb7f766d55db6921d784361b891 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate | 1995-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1996-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0720849-A3 |
| titleOfInvention | Agents for inhibiting the production of IL-1beta and the release of TNFalpha |
| abstract | The pharmaceutical use of 1-cinnamoyl-2-pyrrolidinone nderivatives having the activities to inhibit nthe production of IL-1β and the release of TNFα. Those nderivatives are useful in the treatment or prophylaxis of nthe diseases such as chronic rheumatism and sepsis. |
| priorityDate | 1994-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.